Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 06 tags : Trial save search
Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection
Published: 2021-12-06 (Crawled : 23:00) - biospace.com/
MRK | $125.06 -0.9% 0.0% 5.6M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
trials trial clinical trials infection phase 3 hiv enroll infections
Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome
Published: 2021-12-06 (Crawled : 22:00) - biospace.com/
ACAD M | $17.09 1.18% 1.17% 980K
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
trial positive results phase 3 syndros topline rett syndrome
Ventyx Biosciences Announces First Patient Dosed in a Phase 2 Clinical Trial of VTX002 for the Treatment of Moderate-to-Severe Ulcerative Colitis
Published: 2021-12-06 (Crawled : 22:00) - biospace.com/
VTYX | $4.76 1.93% 1.89% 660K
|
Manufacturing
|
| O: -1.39%
H: 0.0%
C: 0.0%
treatment phase 2 trial bioscience ulcerative colitis
IO Biotech Announces Third Clinical Collaboration with Merck to Evaluate IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) as First-Line Treatment in a Phase 2 Multi-Arm Basket Trial
Published: 2021-12-06 (Crawled : 22:00) - biospace.com/
IOBT | $1.5 -0.66% -0.67% 100K
|
|
| O: -5.23%
H: 0.0%
C: 0.0%
treatment phase 2 trial keytruda collaboration biotech iot
Industrial Degreaser Market Size by Revenue to Reach USD 24.3 Billion by 2026 - Arizton
Published: 2021-12-06 (Crawled : 22:00) - prnewswire.com
SCL M | $82.32 -1.08% 0.0% 48K
|
Process Industries
|
| O: 4.04%
H: 0.0%
C: -2.36%
trial
Trials Show Hope on the Horizon for Dravet Syndrome, Glioblastoma
Published: 2021-12-06 (Crawled : 19:00) - biospace.com/
KZIA | $0.291 -5.21% -5.5% 310K
|
Health Technology
|
| O: -16.26%
H: 0.0%
C: 0.0%
trials trial syndros glioblastoma dravet syndrome
PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationInstitutional Review Board (IRB) approval has been obtained and clinical trial recruitment resumes
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
PDSB | $2.8 -0.71% -0.71% 710K
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
phase 2 trial approval cancer biotech iot
Fulcrum Therapeutics® Announces Additional HBG mRNA Induction from Higher Dose Cohorts in Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease and New Preclinical Mechanism Data
Published: 2021-12-06 (Crawled : 15:00) - biospace.com/
FULC | $7.4 0.54% 0.54% 460K
|
Health Technology
|
| O: -0.78%
H: 0.0%
C: 0.0%
trial therapeutics disease preclinical phase 1 pre-clinical
End Suction Pump Market to Exceed US$ 6.08 by 2031 with Industrial Sector Contributing 3/4th of Overall Sales: FMI
Published: 2021-12-06 (Crawled : 14:30) - prnewswire.com
XYL | $128.0 0.56% 0.0% 1.1M
|
Producer Manufacturing
|
| O: 1.39%
H: 0.0%
C: 0.0%
FLS | $46.38 -0.07% 0.0% 1.1M
|
Producer Manufacturing
|
| O: 1.45%
H: 0.0%
C: 0.0%
sales trial
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ReneSola Ltd. (SOL) Investors to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations
Published: 2021-12-06 (Crawled : 14:30) - prnewswire.com
SOL | $1.85 -0.54% 0.0% 320K
|
Electronic Technology
|
| O: -11.48%
H: 0.0%
C: 0.0%
DOCU S | $57.74 1.89% 1.85% 1.4M
|
Technology Services
|
| O: 0.41%
H: 0.0%
C: 0.0%
trial
NCI-Sponsored Trial of Uproleselan in Older, Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Completes Enrollment of Phase 2 Portion Ahead of Schedule
Published: 2021-12-06 (Crawled : 14:30) - biospace.com/
GLYC | $2.16 -4.21% -4.4% 600K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
phase 2 trial therapy enroll order aml
NRx Announces Completion of Data Safety Meeting for Phase 2 Trial of BriLife Vaccine, Phase 2b/3 Registration Trial to Begin in Nation of Georgia, Israel, European Union, and Other Regions
Published: 2021-12-06 (Crawled : 14:30) - globenewswire.com
NRXP | $4.325 -11.74% -13.29% 270K
|
Manufacturing
|
| O: -1.09%
H: 0.0%
C: 0.0%
israel phase 2 europe phase 2b trial vaccine brilife
Jaguar Health to Host Scientific Discussion about Cancer Therapy-Related Diarrhea in Breast Cancer and the Company’s Ongoing OnTarget Pivotal Phase 3 Trial at San Antonio Breast Cancer Symposium (SABCS 2021)
Published: 2021-12-06 (Crawled : 14:00) - biospace.com/
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
|
| O: -5.69%
H: 0.0%
C: 0.0%
ongoing trial diarrhea therapy cancer phase 3 breast cancer symposium
Acurx Announces First Patient Enrolled in Phase 2b Clinical Trial of its Lead Antibiotic for Treatment of Clostridioides difficile Infection (CDI)
Published: 2021-12-06 (Crawled : 14:00) - biospace.com/
ACXP | $1.6 -2.14% -2.19% 250K
|
Professional, Scientific, and T...
|
| O: 2.41%
H: 4.47%
C: 2.82%
treatment phase 2 phase 2b trial infection iot enroll infections
GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression
Published: 2021-12-06 (Crawled : 14:00) - biospace.com/
GHRS | $10.99 -6.23% -6.64% 37K
|
Manufacturing
|
| O: 0.05%
H: 29.33%
C: 21.8%
treatment phase 2 research trial phase 1 depression
Biohaven Reports Positive Topline Results from Pivotal Migraine Trial of Intranasal Zavegepant Demonstrating Ultra-Rapid Pain Relief by 15 minutes; Prepares for Submission of New Drug Application
Published: 2021-12-06 (Crawled : 13:30) - biospace.com/
BHVN | $43.77 -2.23% 0.0% 1.9M
|
Health Technology
|
| O: -5.67%
H: 0.0%
C: 0.0%
new drug application drug trial migraine topline results positive results topline pain relief submission
180 Life Sciences Provides Follow-Up Information on Oxford University and the Company’s Successful Dupuytren’s Phase 2b Clinical Trial Results
Published: 2021-12-06 (Crawled : 13:30) - globenewswire.com
ATNF | $1.49 -26.78% -36.58% 500K
|
|
| O: -8.71%
H: 0.0%
C: 0.0%
phase 2 phase 2b trial trial results ford results life science
Kronos Bio Announces First Patient Dosed in AGILITY Phase 3 Clinical Trial of Entospletinib in Patients With Newly Diagnosed NPM1-mutated Acute Myeloid Leukemia
Published: 2021-12-06 (Crawled : 12:30) - globenewswire.com
KRON | $1.08 -5.26% -5.56% 260K
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
myeloid leukemia leukemia trial phase 3 acute myeloid leukemia
Sierra Oncology Announces Investor Event to Review MOMENTUM Trial Design and Available Phase 3 Momelotinib Data in Myelofibrosis
Published: 2021-12-06 (Crawled : 12:30) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 3.15%
H: 0.0%
C: 0.0%
fibrosis trial phase 3 designation
Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Disease
Published: 2021-12-06 (Crawled : 12:00) - ocutx.gcs-web.com
OCUL | $7.8 0.0% 1.3M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
dry eye treatment phase 2 eye ocular eye disease trial disease topline results results topline
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.